Figures & data
Figure 1. Analysis of purified recombinant BHc protein during various purification steps by SDS-PAGE and western bolt. The soluble fraction and purified BHc were subjected to 10% SDS-PAGE and Western blot analysis using hyperimmune anti-neurotoxin B serum. Lane 1, pTIG-Trx vector transformed cell lysates; Lane 2, pTIG-Trx-BHc transformed BL21 cell lysates; Lane 3, MMC column purified products; Lane 4, Source 30s column purified products; Lane 5, Western blot analysis; M, protein markers 180, 130, 95, 72(red), 55, 43, 34, 26 and 17 KDa (from top to bottom); An arrow indicates the position of the BHc.
![Figure 1. Analysis of purified recombinant BHc protein during various purification steps by SDS-PAGE and western bolt. The soluble fraction and purified BHc were subjected to 10% SDS-PAGE and Western blot analysis using hyperimmune anti-neurotoxin B serum. Lane 1, pTIG-Trx vector transformed cell lysates; Lane 2, pTIG-Trx-BHc transformed BL21 cell lysates; Lane 3, MMC column purified products; Lane 4, Source 30s column purified products; Lane 5, Western blot analysis; M, protein markers 180, 130, 95, 72(red), 55, 43, 34, 26 and 17 KDa (from top to bottom); An arrow indicates the position of the BHc.](/cms/asset/68a755b6-9620-4571-a861-ddb7d1599543/khvi_a_1547613_f0001_oc.jpg)
Table 1. Survival, group antibody ELISA titers, and serum neutralization titers of mice after vaccination with BHc and mBHC antigens.
Table 2. Survival, group antibody ELISA titers, and serum neutralization titers of mice after vaccination with BHc vaccine.
Figure 2. Survival of mice immunized with BHc vaccine. Mice alive after challenge with a dose of 1000 LD50 of BoNT/B 3 weeks after one injection or 10,000LD50 of BoNT/B 3 weeks after two injections.
![Figure 2. Survival of mice immunized with BHc vaccine. Mice alive after challenge with a dose of 1000 LD50 of BoNT/B 3 weeks after one injection or 10,000LD50 of BoNT/B 3 weeks after two injections.](/cms/asset/891dde93-3fcd-4fe6-84ea-0af2765a7a10/khvi_a_1547613_f0002_b.gif)
Figure 3. Anti-BHc antibody titers in mice vaccinated with one or two doses of BHc formulated with aluminum hydroxide adjuvant. Mice were immunized one or two doses with 0.039 μg to 4 μg of BHc formulated with aluminum hydroxide adjuvant. Sera form individual mice from each group (n = 5) three weeks after final immunization were collected and specific antibody titer were analyzed by ELISA. Serum sample from individual mice sere assayed and the geometric mean titer (GMT) was calculated for each group.
![Figure 3. Anti-BHc antibody titers in mice vaccinated with one or two doses of BHc formulated with aluminum hydroxide adjuvant. Mice were immunized one or two doses with 0.039 μg to 4 μg of BHc formulated with aluminum hydroxide adjuvant. Sera form individual mice from each group (n = 5) three weeks after final immunization were collected and specific antibody titer were analyzed by ELISA. Serum sample from individual mice sere assayed and the geometric mean titer (GMT) was calculated for each group.](/cms/asset/aa3927e7-c65c-4925-b62e-2ab0cc4e3577/khvi_a_1547613_f0003_b.gif)